The massive task of resetting Australia’s COVID-19 vaccine rollout is under way after the federal government secured 20 million additional doses of the Pfizer drug, moves epidemiologists say could allow all adults to be vaccinated by Christmas.
Advice from the Australian Technical Advisory Group on Immunisation suggesting the Oxford-University AstraZeneca drug was not preferred for people under 50 forced the reset, necessary due to the risk from a rare but sometimes fatal blood-clotting issue.
Loading...
Tom McIlroy is the Financial Review’s Canberra bureau chief based in the press gallery at Parliament House. He was previously the AFR’s political correspondent. Connect with Tom on Twitter. Email Tom at thomas.mcilroy@afr.com
Tom Burton has held senior editorial and publishing roles with The Mandarin, The Sydney Morning Herald and as Canberra bureau chief for The Australian Financial Review. He has won three Walkley awards. Connect with Tom on Twitter. Email Tom at tom.burton@afr.com
